Download full catalogue
Your request has been sent.
|
Key Genetic Markers Linked with Ankylosing Spondylitis About IVD |
More |
|
HLA-B27: A Key Genetic Marker in Ankylosing Spondylitis and Related Disorders About IVD |
More |
|
Detecting the Factor V G1691A Mutation – Precision for Thrombophilia Risk Assessment About IVD |
More |
|
Precision in Anticoagulant Therapy: The Role of Genotyping in Warfarin Treatment About IVD |
More |
|
ApoE genetic testing – a tool to prevent side effects during Lecanemab/Leqembi® treatment About IVDTesting |
More |
|
The European Medicines Agency (EMA) recommends dihydropyrimidine dehydrogenase testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine About IVDTesting |
More |
|
CYP2A6 Genotyping for Anticancer Investigational Drug Pharmacogenetic Assessment About IVDTesting |
More |
Your request has been sent.
Thank you for your inquiry
Thank you for your inquiry
Your registration has been sent.
Thank you for your inquiry